Better Therapeutics, Inc.
BTTXDelisted May 16, 2024- Industry
- Services-Health Services
- SEC CIK
- 0001832415
Better Therapeutics, Inc. was delisted on May 16, 2024; its insiders filed their last Form 4 on Feb 13, 2024; 22 institutions reported holding it in 13F filings for Q4 2023, worth $281.2K in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Better Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −6 vs. Q4 2021
- Shares held
- 3.62M
- +82.4K (+2.3%) vs. Q4 2021
- Total value
- $7.16M
- −$9.27M (−56.4%) vs. Q4 2021
- New holders
- 3
- 3 more added
- Sold out
- 9
- 7 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $1 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $37 |
| Q1 2024 | 3 | $1.45K |
| Q4 2023 | 22 | $281.2K |
| Q3 2023 | 18 | $931.1K |
| Q2 2023 | 15 | $1.17M |
| Q1 2023 | 15 | $1.04M |
| Q4 2022 | 17 | $1.75M |
| Q3 2022 | 16 | $3.11M |
| Q2 2022 | 14 | $2.77M |
| Q1 2022 | 14 | $7.16M |
| Q4 2021 | 20 | $16.4M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Better Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Farallon Capital Management, L.L.C. | 1,147,400 | $2.27M | 0.01% | −202,600−15.0% | Reduced |
| Sectoral Asset Management Inc | 878,531 | $1.74M | 0.31% | −95,302−9.8% | Reduced |
| Norges Bank | 597,015 | $1.18M | 0.00% | +597,015 | New |
| Vanguard Group Inc | 284,395 | $563.0K | 0.00% | +80,633+39.6% | Added |
| Victory Capital Management Inc | 272,720 | $540.0K | 0.00% | +272,720 | New |
| Alyeska Investment Group, L.P. | 236,931 | $469.0K | 0.01% | −107,239−31.2% | Reduced |
| Two Sigma Advisers, LP | 70,600 | $140.0K | 0.00% | +12,500+21.5% | Added |
| Two Sigma Investments, LP | 65,792 | $130.0K | 0.00% | −58,957−47.3% | Reduced |
| Geode Capital Management, LLC | 34,847 | $68.0K | 0.00% | +34,847 | New |
| Northern Trust Corp | 16,703 | $33.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 10,535 | $21.0K | 0.00% | −2,178−17.1% | Reduced |
| Tower Research Capital LLC (TRC) | 187 | $0 | 0.00% | −3,726−95.2% | Reduced |
| Wells Fargo & Company | 60 | $0 | 0.00% | +1+1.7% | Added |
| Morgan Stanley | 9 | $0 | 0.00% | −11−55.0% | Reduced |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −217,900−100.0% | Sold out |
| Blue Water Life Science Advisors, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −68,310−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −31,848−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −13,327−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −10,825−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −2,969−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −94−100.0% | Sold out |
| PSI Advisors, LLC | 0 | $0 | 0.00% | −65−100.0% | Sold out |